HealthCor Management
Latest statistics and disclosures from HealthCor Management's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0001409307
Portfolio Holdings for HealthCor Management
HealthCor Management holds 69 positions in its portfolio as reported in the June 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Aetna | 6.7 | $190M | 4.3M | 44.09 |
|
|
| Quest Diagnostics Incorporated (DGX) | 6.7 | $189M | 3.2M | 59.10 |
|
|
| Stryker Corporation (SYK) | 6.0 | $170M | 2.9M | 58.69 |
|
|
| Magellan Health Services | 5.8 | $164M | 3.0M | 54.74 |
|
|
| Allscripts Healthcare Solutions (MDRX) | 4.8 | $136M | 7.0M | 19.42 |
|
|
| Covidien | 4.5 | $128M | 2.4M | 53.23 |
|
|
| Universal Health Services (UHS) | 4.4 | $124M | 2.4M | 51.53 |
|
|
| Cardinal Health (CAH) | 4.2 | $120M | 2.7M | 45.42 |
|
|
| DaVita (DVA) | 4.0 | $113M | 1.3M | 86.61 |
|
|
| Humana (HUM) | 3.7 | $105M | 1.3M | 80.54 |
|
|
| CIGNA Corporation | 2.9 | $82M | 1.6M | 51.43 |
|
|
| PerkinElmer (RVTY) | 2.9 | $81M | 3.0M | 26.91 |
|
|
| Salix Pharmaceuticals | 2.8 | $80M | 2.0M | 39.83 |
|
|
| Sirona Dental Systems | 2.4 | $69M | 1.3M | 53.10 |
|
|
| Cubist Pharmaceuticals | 2.4 | $68M | 1.9M | 35.99 |
|
|
| Pall Corporation | 2.4 | $68M | 1.2M | 56.23 |
|
|
| Nektar Therapeutics (NKTR) | 2.4 | $67M | 9.2M | 7.27 |
|
|
| United Therapeutics Corporation (UTHR) | 2.2 | $63M | 1.2M | 55.10 |
|
|
| Baxter International (BAX) | 2.1 | $60M | 1.0M | 59.69 |
|
|
| Fortune Brands | 2.0 | $57M | 900k | 63.77 |
|
|
| CareFusion Corporation | 1.9 | $54M | 2.0M | 27.17 |
|
|
| WellCare Health Plans | 1.8 | $52M | 1.0M | 51.41 |
|
|
| Tenet Healthcare Corporation | 1.8 | $51M | 8.1M | 6.24 |
|
|
| Gilead Sciences (GILD) | 1.5 | $41M | 1.0M | 41.41 |
|
|
| Newell Rubbermaid (NWL) | 1.4 | $40M | 2.5M | 15.78 |
|
|
| Corning Incorporated (GLW) | 1.3 | $36M | 2.0M | 18.15 |
|
|
| VCA Antech | 1.1 | $32M | 1.5M | 21.20 |
|
|
| eHealth (EHTH) | 1.1 | $30M | 2.3M | 13.36 |
|
|
| Coca-cola Enterprises | 1.0 | $29M | 1.0M | 29.18 |
|
|
| Amarin Corporation (AMRN) | 1.0 | $29M | 2.0M | 14.43 |
|
|
| Dendreon Corporation | 0.8 | $24M | 600k | 39.44 |
|
|
| CorVel Corporation (CRVL) | 0.8 | $24M | 500k | 46.90 |
|
|
| Ym Biosciences | 0.8 | $24M | 8.4M | 2.81 |
|
|
| InterMune | 0.8 | $23M | 650k | 35.85 |
|
|
| Alnylam Pharmaceuticals (ALNY) | 0.6 | $17M | 1.8M | 9.37 |
|
|
| ArthroCare Corporation | 0.6 | $17M | 493k | 33.47 |
|
|
| Rigel Pharmaceuticals (RIGL) | 0.5 | $14M | 1.5M | 9.17 |
|
|
| J.M. Smucker Company (SJM) | 0.5 | $13M | 175k | 76.44 |
|
|
| Life Technologies | 0.5 | $13M | 250k | 52.07 |
|
|
| ArQule | 0.4 | $13M | 2.0M | 6.25 |
|
|
| NPS Pharmaceuticals | 0.4 | $12M | 1.3M | 9.45 |
|
|
| Trimeris | 0.4 | $11M | 4.4M | 2.47 |
|
|
| Mead Johnson Nutrition | 0.4 | $10M | 150k | 67.55 |
|
|
| Affymax (AFFY) | 0.4 | $10M | 1.5M | 6.87 |
|
|
| Anthera Pharmaceuticals | 0.3 | $9.8M | 1.2M | 8.17 |
|
|
| Allos Therapeutics | 0.3 | $9.5M | 4.5M | 2.14 |
|
|
| Wright Medical | 0.3 | $9.3M | 620k | 15.00 |
|
|
| Becton, Dickinson and (BDX) | 0.3 | $8.9M | 103k | 86.17 |
|
|
| Celldex Therapeutics | 0.3 | $8.9M | 2.5M | 3.55 |
|
|
| AmerisourceBergen (COR) | 0.3 | $7.9M | 190k | 41.40 |
|
|
| Sanofi Aventis Wi Conval Rt | 0.2 | $6.0M | 2.5M | 2.41 |
|
|
| Merit Medical Systems (MMSI) | 0.1 | $3.6M | 200k | 17.97 |
|
|
| RTI Biologics | 0.1 | $2.8M | 1.0M | 2.71 |
|
|
| Gen-Probe Incorporated | 0.1 | $2.4M | 34k | 69.15 |
|
|
| Johnson & Johnson (JNJ) | 0.1 | $1.7M | 25k | 66.52 |
|
|
| Express Scripts | 0.1 | $1.4M | 25k | 54.00 |
|
|
| Merck & Co (MRK) | 0.0 | $1.2M | 35k | 35.29 |
|
|
| UnitedHealth (UNH) | 0.0 | $1.0M | 20k | 51.60 |
|
|
| Abbott Laboratories (ABT) | 0.0 | $789k | 15k | 52.60 |
|
|
| McKesson Corporation (MCK) | 0.0 | $837k | 10k | 83.70 |
|
|
| Pfizer (PFE) | 0.0 | $515k | 25k | 20.60 |
|
|
| Bristol Myers Squibb (BMY) | 0.0 | $492k | 17k | 28.94 |
|
|
| Thermo Fisher Scientific (TMO) | 0.0 | $476k | 7.4k | 64.32 |
|
|
| Allergan | 0.0 | $624k | 7.5k | 83.20 |
|
|
| Henry Schein (HSIC) | 0.0 | $501k | 7.0k | 71.57 |
|
|
| Zimmer Holdings (ZBH) | 0.0 | $632k | 10k | 63.20 |
|
|
| Watson Pharmaceuticals | 0.0 | $515k | 7.5k | 68.67 |
|
|
| Agilent Technologies Inc C ommon (A) | 0.0 | $332k | 6.5k | 51.08 |
|
|
| Hi-Tech Pharmacal | 0.0 | $321k | 11k | 28.89 |
|
Past Filings by HealthCor Management
SEC 13F filings are viewable for HealthCor Management going back to 2011
- HealthCor Management 2011 Q2 filed Aug. 15, 2011